Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: May 2022

MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Executing Aggressive Growth Strategy

Posted on May 6, 2022 by MissionIR

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is focused on combatting climate change and contributing to a sustainable future as an independent renewable energy producer that acquires, develops, builds, owns, and operates a portfolio of renewable natural gas (“RNG”), waste-to-energy, and related … Continue reading →

Posted in EverGen Infrastructure Corp. EVGIF | Leave a comment

MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Expanding into Live Resin Vapes Segment to Capitalize on Growing Market

Posted on May 6, 2022 by MissionIR

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF) recently announced the rollout of Platinum Vape(TM) (“PV”) Live Resin in Michigan, fulfilling its promise to introduce a steady stream of new products and consumption options to satisfy demand in the state. … Continue reading →

Posted in Red White & Bloom Brands Inc. RWBYF | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results

Posted on May 6, 2022 by MissionIR

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and operating results for its fiscal … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial

Posted on May 6, 2022 by MissionIR

Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause of mental disability worldwide Preclinical … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’

Posted on May 5, 2022 by MissionIR

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma multiforme (“GBM”). On average, GBM … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York

Posted on May 5, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads, “Seven years ago yesterday, on … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Readying Human Study to Compare Lexaria’s DehydraTECH-Nicotine Pouch Performance to that of Existing Leading Brands

Posted on May 5, 2022 by MissionIR

In its most recent oral nicotine study, Lexaria established that DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls and peak levels achieved were up to 10x higher than controls Lexaria hopes to evidence in its upcoming … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) Preclinical Study Findings to Be Showcased at Global Event Focused on Psychedelic-Assisted Therapy

Posted on May 5, 2022 by MissionIR

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that an abstract highlighting preclinical data for its deuterated psilocybin analog CYB003 has been selected for a poster presentation at the “From Research … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) to Show High-Performance FIVE RS during Roadshow Tour

Posted on May 5, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has announced that it will be adding its Mullen FIVE RS model to its summer roadshow tour. The company has been touring the country in what it calls a “strikingly … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science

Posted on May 5, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced that its subsidiary, BayMedica, will be providing rare cannabinoids for use in Radicle Science Inc.’s Radicle Energy rare cannabinoid … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment